Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background/Aims: The prediction of clinical outcomes in patients with chronic hepatitis B (CHB) is paramount for effective management. This study aimed to evaluate the prognostic value of computed tomography (CT) analysis using deep learning algorithms in patients with CHB. Methods: This retrospective study included 2,169 patients with CHB without hepatic decompensation who underwent contrast-enhanced abdominal CT for hepatocellular carcinoma (HCC) surveillance between January 2005 and June 2016. Liver and spleen volumes and body composition measurements including subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT), and skeletal muscle indices were acquired from CT images using deep learning-based fully automated organ segmentation algorithms. We assessed the significant predictors of HCC, hepatic decompensation, diabetes mellitus (DM), and overall survival (OS) using Cox proportional hazard analyses. Results: During a median follow-up period of 103.0 months, HCC (n=134, 6.2%), hepatic decompensation (n=103, 4.7%), DM (n=432, 19.9%), and death (n=120, 5.5%) occurred. According to the multivariate analysis, standardized spleen volume significantly predicted HCC development (hazard ratio [HR]=1.01, P=0.025), along with age, sex, albumin and platelet count. Standardized spleen volume (HR=1.01, P<0.001) and VAT index (HR=0.98, P=0.004) were significantly associated with hepatic decompensation along with age and albumin. Furthermore, VAT index (HR=1.01, P=0.001) and standardized spleen volume (HR=1.01, P=0.001) were significant predictors for DM, along with sex, age, and albumin. SAT index (HR=0.99, P=0.004) was significantly associated with OS, along with age, albumin, and MELD. Conclusions: Deep learning-based automatically measured spleen volume, VAT, and SAT indices may provide various prognostic information in patients with CHB.
Abstract
Background/Aims: The prediction of clinical outcomes in patients with chronic hepatitis B (CHB) is paramount for effective management. This study aimed to evaluate the prognostic value of computed tomography (CT) analysis using deep learning algorithms in patients with CHB. Methods: This retrospective study included 2,169 patients with CHB without hepatic decompensation who underwent contrast-enhanced abdominal CT for hepatocellular carcinoma (HCC) surveillance between January 2005 and June 2016. Liver and spleen volumes and body composition measurements including subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT), and skeletal muscle indices were acquired from CT images using deep learning-based fully automated organ segmentation algorithms. We assessed the significant predictors of HCC, hepatic decompensation, diabetes mellitus (DM), and overall survival (OS) using Cox proportional hazard analyses. Results: During a median follow-up period of 103.0 months, HCC (n=134, 6.2%), hepatic decompensation (n=103, 4.7%), DM (n=432, 19.9%), and death (n=120, 5.5%) occurred. According to the multivariate analysis, standardized spleen volume significantly predicted HCC development (hazard ratio [HR]=1.01, P=0.025), along with age, sex, albumin and platelet count. Standardized spleen volume (HR=1.01, P<0.001) and VAT index (HR=0.98, P=0.004) were significantly associated with hepatic decompensation along with age and albumin. Furthermore, VAT index (HR=1.01, P=0.001) and standardized spleen volume (HR=1.01, P=0.001) were significant predictors for DM, along with sex, age, and albumin. SAT index (HR=0.99, P=0.004) was significantly associated with OS, along with age, albumin, and MELD. Conclusions: Deep learning-based automatically measured spleen volume, VAT, and SAT indices may provide various prognostic information in patients with CHB.
참고문헌 (49)
- European Association for the Study of the Liver, "EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection", J Hepatol, 67, pp.370~398 (2017)
- European Association for the Study of the Liver, "EASL clinical practice guidelines : Management of chronic hepatitis B virus infection", J Hepatol, 57, pp.167~185 (2012)
- Raffetti E, "Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B : a systematic review and meta-analysis", Liver Int, 36, pp.1239~1251 (2016)
- Varbobitis I, "The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy", Clin Mol Hepatol, 22, pp.319~326 (2016)
- Yuen MF, "Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B", J Hepatol, 50, pp.80~88 (2009)
- Wong VW, "Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers", J Clin Oncol, 28, pp.1660~1665 (2010)
- Chen CJ, "Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level", JAMA, 295, pp.65~73 (2006)
- Papatheodoridis G, "PAGE-B predictsthe risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy", J Hepatol, 64, pp.800~806 (2016)
- Ripoll C, "Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis", Gastroenterology, 133, pp.481~488 (2007)
- Ripoll C, "Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era", Hepatology, 42, pp.793~801 (2005)
- Weston AD, "Automated abdominal segmentation of CT scans for body composition analysis using deep learning", Radiology, 290, pp.669~679 (2019)
- Lee YS, "Deep neural network for automatic volumetric segmentation of whole-body CT images for body composition assessment", Clin Nutr, 40, pp.5038~5046 (2021)
- Pickhardt PJ, "Automated CT biomarkers for opportunistic prediction of future cardiovascular events and mortality in an asymptomatic screening population : a retrospective cohort study", Lancet Digit Health, 2, pp.e192~e200 (2020)
- Pickhardt PJ, "AI-based opportunistic CT screening of incidental cardiovascular disease, osteoporosis, and sarcopenia: cost-effectiveness analysis", Abdom Radiol(NY), 48, pp.1181~1198 (2023)
- Sakamoto T, "Sarcopenia as a prognostic factor in patients with recurrent pancreatic cancer : a retrospective study", World J Surg Oncol, 18, pp.221~ (2020)
- Jang M, "Predictive value of sarcopenia and visceral obesity for postoperative pancreatic fistula after pancreaticoduodenectomy analyzed on clinically acquired CT and MRI", Eur Radiol, 29, pp.2417~2425 (2019)
- Pecorelli N, "Impact of sarcopenic obesity on failure to rescue from major complicationsfollowing pancreaticoduodenectomy for cancer : Results from a multicenter study", Ann Surg Oncol, 25, pp.308~317 (2018)
- Du Bois D, "A formula to estimate the approximate surface area if height and weight be known. 1916", Nutrition, 5, pp.303~311 (1989)
- "CT/MRI LI-RADS® v2018 core"[URL]
- Korean Liver Cancer Association (KLCA), "2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma", Clinical and Molecular Hepatology, 28(4), pp.583~705 (2022), 대한간학회
- D’Amico G, "Natural history and prognostic indicators of survival in cirrhosis : a systematic review of 118 studies", J Hepatol, 44, pp.217~231 (2006)
- Contal C, "An application of changepoint methods in studying the effect of age on survival in breast cancer", Computational Statistics & Data Analysis, 30, pp.253~270 (1999)
- Terrault NA, "Update on prevention, diagnosis, and treatment of chronic hepatitis B : AASLD 2018 hepatitis B guidance", Hepatology, 67, pp.1560~1599 (2018)
- European Association for the Study of the Liver, "EASL Clinical Practice Guidelines : Management of hepatocellular carcinoma", J Hepatol, 69, pp.182~236 (2018)
- 김동환, "Current status of image-based surveillance in hepatocellular carcinoma", ULTRASONOGRAPHY, 40(1), pp.45~56 (2021), 대한초음파의학회[DOI]
- Jang S, "Opportunistic osteoporosis screening at routine abdominal and thoracic CT : Normative L1 trabecular attenuation valuesin more than 20 000 adults", Radiology, 291, pp.360~367 (2019)
- van der Werf A, "Percentilesforskeletal muscle index, area and radiation attenuation based on computed tomography imaging in a healthy Caucasian population", Eur J Clin Nutr, 72, pp.288~296 (2018)
- Bolognesi M, "Role of spleen enlargement in cirrhosis with portal hypertension", Dig Liver Dis, 34, pp.144~150 (2002)
- Gracia-Sancho J, "Hepatic microcirculation and mechanisms of portal hypertension", Nat Rev Gastroenterol Hepatol, 16, pp.221~234 (2019)
- Iranmanesh P, "Accurate computed tomography-based portal pressure assessment in patients with hepatocellular carcinoma", J Hepatol, 60, pp.969~974 (2014)
- Liu P, "Liver and spleen volume variations in patients with hepatic fibrosis", World J Gastroenterol, 15, pp.3298~3302 (2009)
- Yoo J, "Prognostic role of spleen volume measurement using computed tomography in patients with compensated chronic liver disease from hepatitis B viral infection", Eur Radiol, 31, pp.1432~1442 (2021)
- Berzigotti A, "Spleen enlargement on follow-up evaluation : a noninvasive predictor of complications of portal hypertension in cirrhosis", Clin Gastroenterol Hepatol, 6, pp.1129~1134 (2008)
- Papatheodoridis GV, "Diabetes mellitus in chronic hepatitis B and C : prevalence and potential association with the extent of liver fibrosis", J Viral Hepat, 13, pp.303~310 (2006)
- Cai C, "Association between hepatitis B virus infection and diabetes mellitus : A metaanalysis", Exp Ther Med, 10, pp.693~698 (2015)
- Antonelli A, "Hepatitis C virus infection : evidence for an association with type 2 diabetes", Diabetes Care, 28, pp.2548~2550 (2005)
- Huang ZS, "Asymptomatic chronic hepatitis B virusinfection does not increase the risk of diabetes mellitus : a ten-year observation", J Gastroenterol Hepatol, 25, pp.1420~1425 (2010)
- Tappy L, "New data and new concepts on the role of the liver in glucose homeostasis", Curr Opin Clin Nutr Metab Care, 4, pp.273~277 (2001)
- Berzigotti A, "Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis", Hepatology, 54, pp.555~561 (2011)
- Berzigotti A, "Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity : The SportDietstudy", Hepatology, 65, pp.1293~1305 (2017)
- Ahn JC, "Obesity and liver decompensation", Clin Liver Dis(Hoboken), 14, pp.12~15 (2019)
- Blaszczak AM, "Adipocytes, innate immunity and obesity : A mini-review", Front Immunol, 12, pp.650768~ (2021)
- Herold J, "Angiogenesis in adipose tissue : the interplay between adipose and endothelial cells", Front Physiol, 11, pp.624903~ (2021)
- Frayn KN, "Visceral fat and insulin resistance--causative or correlative?", Br J Nutr, 83(Suppl 1), pp.S71~S77 (2000)
- Gastaldelli A, "Metabolic effects of visceral fat accumulation in type 2 diabetes", J Clin Endocrinol Metab, 87, pp.5098~5103 (2002)
- Charette N, "Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer : a post hoc analysis of two nonrandomized phase II trials", BMC Cancer, 19, pp.134~ (2019)
- Ebadi M, "Subcutaneous adiposity is an independent predictor of mortality in cancer patients", Br J Cancer, 117, pp.148~155 (2017)
- Yu Q, "Spleen volume-based non-invasive tool for predicting hepatic decompensation in people with compensated cirrhosis(CHESS1701)", JHEP Rep, 4, pp.100575~ (2022)
- Kim JM, "Impact of subcutaneous and visceral fat adiposity in patients with colorectal cancer", Clin Nutr, 40, pp.5631~5638 (2021)